Acrophobia
11
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Hypnosis Induction and Height Experience in VR - Control Group Comparison and Three Sessions
Virtual Reality Intervention for Fear of Heights
Virtual Reality Exposure Therapy for Acrophobia
CBM in the Context of Exposure for Acrophobia
Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia
Augmenting Virtual Reality Exposure Therapy for Acrophobia
Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights
Intelligent Virtual Reality Therapy System and Testing Its Clinical Efficacy
Single Session Virtual Reality Therapy in Acrophobia - and the Role of Respiration
Virtual Reality and Brain Stimulation, an Experiential Approach
3D Video Virtual Reality Exposure Therapy Study